| PBM Stock | | | USD 3.51 0.17 5.09% |
This module uses fundamental data of Psyence Biomedical to approximate its Piotroski F score. Psyence Biomedical F Score is determined by combining nine binary scores representing 3 distinct fundamental categories of Psyence Biomedical Ltd. These three categories are profitability, efficiency, and funding. Some research analysts and sophisticated value traders use Piotroski F Score to find opportunities outside of the conventional market and financial statement analysis.They believe that some of the new information about Psyence Biomedical financial position does not get reflected in the current market share price suggesting a possibility of arbitrage. Check out
Psyence Biomedical Altman Z Score,
Psyence Biomedical Correlation,
Psyence Biomedical Valuation, as well as analyze
Psyence Biomedical Alpha and Beta and
Psyence Biomedical Hype Analysis.
As of the 29th of November 2024,
Net Debt is likely to grow to about 10.2
M, while
Short and Long Term Debt Total is likely to drop about 8.4
M. As of the 29th of November 2024,
Current Ratio is likely to drop to 0.09. In addition to that,
Company Equity Multiplier is likely to grow to -0.1
At this time, it appears that Psyence Biomedical's Piotroski F Score is Frail. Although some professional money managers and academia have recently criticized
Piotroski F-Score model, we still consider it an effective method of
predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
3.0
Piotroski F Score - Frail
| Change in Return on Assets | |
| Cash Flow Return on Assets | |
| Current Quality of Earnings (accrual) | |
| Long Term Debt Over Assets Change | |
| Change In Outstending Shares | |
Psyence Biomedical Piotroski F Score Drivers
The critical factor to consider when applying the Piotroski F Score to Psyence Biomedical is to make sure Psyence is not a subject of accounting manipulations and runs a healthy internal audit department. So, if Psyence Biomedical's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if Psyence Biomedical's financial numbers are properly reported.
Psyence Biomedical F Score Driver Matrix
One of the toughest challenges investors face today is learning how to quickly synthesize historical
financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between Psyence Biomedical's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Psyence Biomedical in a much-optimized way.
Click cells to compare fundamentals
About Psyence Biomedical Piotroski F Score
F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled
Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.
About Psyence Biomedical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Psyence Biomedical Ltd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Psyence Biomedical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at
the intrinsic value of Psyence Biomedical Ltd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing
financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our
fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectWhen determining whether Psyence Biomedical is a strong investment it is important to analyze Psyence Biomedical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Psyence Biomedical's
future performance.
For an informed investment choice regarding Psyence Stock, refer to the following important reports: Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost
the valuation of Psyence Biomedical. If investors know Psyence will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Psyence Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share | Return On Assets |
The market value of Psyence Biomedical is measured differently than its book value, which is the value of Psyence that is recorded on the company's balance sheet. Investors also form their own opinion of Psyence Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Psyence Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Psyence Biomedical's market value can be influenced by many factors that don't directly affect Psyence Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Psyence Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine
if Psyence Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Psyence Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.